Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (GDRX) operates a leading digital healthcare platform that transforms prescription affordability through price transparency tools and pharmacy benefit solutions. This news hub provides investors and industry professionals with essential updates on financial performance, strategic initiatives, and regulatory developments impacting the company’s role in reshaping medication access.
Discover official press releases covering quarterly earnings, partnership announcements with healthcare stakeholders, and expansions of the company’s prescription savings ecosystem. Our curated collection includes analyses of market trends affecting GoodRx’s position in digital health, updates on telehealth integrations, and coverage of consumer affordability programs.
Key updates include developments in PBM collaborations, Medicare/Medicaid pricing initiatives, and technological advancements within the GoodRx platform. Bookmark this page to monitor how the company navigates evolving healthcare regulations while maintaining its mission to reduce out-of-pocket medication costs for millions of Americans.
GoodRx (GDRX) has launched a Vaccine Guide to assist users in navigating the rollout of the COVID-19 vaccine. Collaborating with the CDC and VaccineFinder, GoodRx tracks vaccine availability at over 50,000 locations, including pharmacies and clinics. The guide allows consumers to find vaccination appointments and the types of vaccines available. Notably, more than 1.8 million Americans have subscribed for text alerts on local eligibility and updates. GoodRx has saved Americans over $25 billion in healthcare costs since 2011, becoming the #1 downloaded medical app in the last three years.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its fourth quarter and full year 2020 financial results, emphasizing its role as a leading healthcare savings resource. The company has facilitated over $25 billion in savings for Americans since 2011. Investors can access the full results and a shareholder letter on the company's investor relations website. A conference call is scheduled for March 11, 2021, at 2:00 p.m. PT to discuss these results further.
GoodRx has launched GoodRx Helps, a philanthropic initiative offering free prescriptions to patients facing financial barriers. In partnership with the National Association of Free and Charitable Clinics, GoodRx aims to subsidize nearly 1,000 medications across 23 clinics, targeting underserved communities. Following its IPO, the company has allocated over $40 million to this program, projecting to provide over $5 million in medications in 2021. This initiative comes amid rising healthcare costs and a significant increase in unemployment due to the pandemic, which has left millions without insurance.
GoodRx Holdings Inc. (Nasdaq: GDRX) is set to report its fourth quarter and full year 2020 financial results on March 11, 2021, after market close. A conference call will be held at 2:00 p.m. PT to discuss the results and the company's business outlook. Investors can access the call via a webcast at investors.goodrx.com. GoodRx is recognized for helping Americans save on healthcare, having facilitated over $25 billion in savings since 2011, and remains the top downloaded medical app.
GoodRx Holdings (Nasdaq: GDRX) announced its participation in upcoming virtual investor conferences. Executives will present at the Goldman Sachs Technology and Internet Conference on January 12 at 11:50 a.m. PT and the J.P. Morgan Healthcare Conference on January 13 at the same time. The presentations will be available via live webcast and archived on the Company's Investor Relations website for at least 30 days. GoodRx, a leading digital healthcare platform, has helped Americans save over $25 billion since 2011.
GoodRx (GDRX) has expanded benefits for its subscription service, GoodRx Gold, offering members exclusive discounts on online doctor visits and free mail delivery. Members can now access affordable healthcare from home, with telehealth visits starting at $10. The service includes mail delivery for over 1,000 medications, with many under $10. After a 30-day free trial, the subscription costs $5.99 monthly for individuals and $9.99 for families. The average member saves over $2,875 annually. GoodRx aims to enhance access to healthcare as telehealth interest rises post-COVID-19 pandemic.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its third quarter 2020 financial results, highlighting its ongoing mission to make healthcare affordable. With over $25 billion saved by Americans since 2011, GoodRx remains a leading resource for healthcare savings, providing affordable prescriptions and telehealth services. Investors can access the Q3 results and shareholder letter on the investor relations website. A conference call is scheduled for today to discuss these results and the company’s outlook.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced participation in several upcoming virtual investor conferences. Key events include the RBC Capital Markets Conference on November 18 at 7:15am PT, the Credit Suisse Technology Conference on December 3 at 9:50am PT, the UBS Global TMT Conference on December 8 at 11:50am PT, and the Barclays Global Conference on December 10 at 10:00am PT. Live webcasts and archived recordings will be available on the Company’s Investor Relations website post-conference.
GoodRx has saved Americans over $20 billion since 2011.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced the release of its third quarter 2020 financial results on November 12, 2020, before the U.S. market opens. A conference call will follow at 5:30 a.m. PT to discuss the results and future outlook. The company has aided Americans in saving over $20 billion since 2011. GoodRx is recognized as the #1 most downloaded medical app over the past three years, reflecting its strong market presence in consumer-focused digital healthcare.
FAQ
What is the current stock price of Goodrx Holdings (GDRX)?
What is the market cap of Goodrx Holdings (GDRX)?
